tiprankstipranks
United Therapeutics Corp. (UTHR)
NASDAQ:UTHR
US Market
UTHR
United Therapeutics
RESEARCH TOOLSreports
Want to see UTHR full AI Analyst Report?

United Therapeutics (UTHR) Ratios

723 Followers

United Therapeutics Ratios

UTHR's free cash flow for Q1 2026 was $0.83. For the 2026 fiscal year, UTHR's free cash flow was decreased by $ and operating cash flow was $0.42. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.79 6.60 5.25 4.41 9.85
Quick Ratio
 4.50 6.28 5.03 4.28 9.55
Cash Ratio
 1.79 2.78 2.30 1.50 2.80
Solvency Ratio
 1.69 1.81 1.38 0.88 0.62
Operating Cash Flow Ratio
 2.61 2.78 1.80 1.22 2.34
Short-Term Operating Cash Flow Coverage
 0.00 0.00 4.42 2.44 0.00
Net Current Asset Value
$ 2.06B$ 2.92B$ 2.95B$ 2.37B$ 2.13B
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.04 0.10 0.13
Debt-to-Equity Ratio
 0.00 0.00 0.05 0.12 0.17
Debt-to-Capital Ratio
 0.00 0.00 0.04 0.10 0.14
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.05 0.14
Financial Leverage Ratio
 1.14 1.11 1.14 1.20 1.26
Debt Service Coverage Ratio
 85.16 73.84 3.82 2.39 25.22
Interest Coverage Ratio
 87.63 77.81 32.10 19.98 30.24
Debt to Market Cap
 0.00 0.00 0.02 0.07 0.06
Interest Debt Per Share
 0.38 0.44 7.59 16.22 18.29
Net Debt to EBITDA
 -0.63 -0.86 -0.84 -0.37 -0.15
Profitability Margins
Gross Profit Margin
86.58%87.92%89.24%88.94%92.42%
EBIT Margin
51.41%54.46%54.98%57.30%51.08%
EBITDA Margin
54.20%57.15%57.50%59.58%53.73%
Operating Profit Margin
45.34%47.67%47.86%50.91%50.60%
Pretax Profit Margin
50.75%53.85%53.49%54.75%49.09%
Net Profit Margin
40.61%41.94%41.53%42.31%37.56%
Continuous Operations Profit Margin
40.61%41.94%41.53%42.31%37.56%
Net Income Per EBT
80.03%77.88%77.65%77.28%76.51%
EBT Per EBIT
111.94%112.96%111.76%107.54%97.03%
Return on Assets (ROA)
19.17%16.94%16.23%13.74%12.03%
Return on Equity (ROE)
19.24%18.81%18.55%16.46%15.16%
Return on Capital Employed (ROCE)
23.50%20.73%20.78%18.62%17.18%
Return on Invested Capital (ROIC)
18.81%16.14%15.44%13.54%13.15%
Return on Tangible Assets
19.51%17.19%16.48%13.96%12.12%
Earnings Yield
5.23%6.18%7.49%9.57%5.75%
Efficiency Ratios
Receivables Turnover
 10.16 9.09 10.30 8.35 8.79
Payables Turnover
 0.85 0.00 51.62 45.98 35.78
Inventory Turnover
 2.39 2.10 1.96 2.30 1.44
Fixed Asset Turnover
 1.72 1.84 2.35 2.23 2.25
Asset Turnover
 0.47 0.40 0.39 0.32 0.32
Working Capital Turnover Ratio
 1.17 1.01 0.98 0.80 0.77
Cash Conversion Cycle
 -238.70 214.02 214.45 194.27 285.13
Days of Sales Outstanding
 35.93 40.16 35.43 43.74 41.55
Days of Inventory Outstanding
 153.02 173.86 186.09 158.47 253.78
Days of Payables Outstanding
 427.65 0.00 7.07 7.94 10.20
Operating Cycle
 188.95 214.02 221.52 202.21 295.33
Cash Flow Ratios
Operating Cash Flow Per Share
 35.94 35.24 29.36 20.90 17.64
Free Cash Flow Per Share
 23.38 23.49 23.91 15.97 14.59
CapEx Per Share
 12.56 11.75 5.45 4.92 3.05
Free Cash Flow to Operating Cash Flow
 0.65 0.67 0.81 0.76 0.83
Dividend Paid and CapEx Coverage Ratio
 2.86 3.00 5.38 4.24 5.78
Capital Expenditure Coverage Ratio
 2.86 3.00 5.38 4.24 5.78
Operating Cash Flow Coverage Ratio
 0.00 0.00 4.42 1.40 1.00
Operating Cash Flow to Sales Ratio
 0.49 0.49 0.46 0.42 0.41
Free Cash Flow Yield
4.23%4.82%6.78%7.26%5.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 19.12 16.17 13.34 10.45 17.40
Price-to-Sales (P/S) Ratio
 7.58 6.78 5.54 4.42 6.53
Price-to-Book (P/B) Ratio
 4.17 3.04 2.47 1.72 2.64
Price-to-Free Cash Flow (P/FCF) Ratio
 23.62 20.74 14.76 13.77 19.06
Price-to-Operating Cash Flow Ratio
 15.75 13.83 12.02 10.52 15.77
Price-to-Earnings Growth (PEG) Ratio
 2.40 1.16 0.52 0.33 0.34
Price-to-Fair Value
 4.17 3.04 2.47 1.72 2.64
Enterprise Value Multiple
 13.36 11.01 8.80 7.05 12.01
Enterprise Value
 22.95B 20.03B 14.55B 9.78B 12.49B
EV to EBITDA
 13.36 11.01 8.80 7.05 12.01
EV to Sales
 7.24 6.29 5.06 4.20 6.45
EV to Free Cash Flow
 22.56 19.24 13.47 13.09 18.82
EV to Operating Cash Flow
 14.68 12.83 10.96 10.00 15.57
Tangible Book Value Per Share
 133.00 157.56 140.09 125.44 104.44
Shareholders’ Equity Per Share
 135.66 160.19 142.57 127.88 105.42
Tax and Other Ratios
Effective Tax Rate
 0.20 0.22 0.22 0.23 0.23
Revenue Per Share
 72.87 71.84 63.66 49.73 42.56
Net Income Per Share
 29.60 30.13 26.44 21.04 15.98
Tax Burden
 0.80 0.78 0.78 0.77 0.77
Interest Burden
 0.99 0.99 0.97 0.96 0.96
Research & Development to Revenue
 0.17 0.17 0.17 0.18 0.17
SG&A to Revenue
 0.24 0.23 0.22 0.17 0.21
Stock-Based Compensation to Revenue
 0.04 0.05 0.05 0.02 0.06
Income Quality
 1.21 1.17 1.11 0.99 1.10
Currency in USD